155 related articles for article (PubMed ID: 25457251)
1. A preliminary study on surgery for hepatocellular carcinoma patients with portal hypertension.
Duan YF; Li XD; Sun DL; Chen XM; An Y; Zhu F
Am J Surg; 2015 Jul; 210(1):129-33. PubMed ID: 25457251
[TBL] [Abstract][Full Text] [Related]
2. [Role of united hepatectomy and splenectomy in the surgical treatment of hepatocellular carcinoma complicated with hepatic cirrhosis and hypersplenism].
Chen XP; Wu ZD; Qiu FZ
Zhonghua Wai Ke Za Zhi; 2005 Apr; 43(7):442-6. PubMed ID: 15854370
[TBL] [Abstract][Full Text] [Related]
3. Portal hypertension: contraindication to liver surgery?
Capussotti L; Ferrero A; Viganò L; Muratore A; Polastri R; Bouzari H
World J Surg; 2006 Jun; 30(6):992-9. PubMed ID: 16736327
[TBL] [Abstract][Full Text] [Related]
4. Is portal hypertension a contraindication to hepatic resection?
Cucchetti A; Ercolani G; Vivarelli M; Cescon M; Ravaioli M; Ramacciato G; Grazi GL; Pinna AD
Ann Surg; 2009 Dec; 250(6):922-8. PubMed ID: 19855258
[TBL] [Abstract][Full Text] [Related]
5. Influence of clinically significant portal hypertension on survival after hepatic resection for hepatocellular carcinoma in cirrhotic patients.
Giannini EG; Savarino V; Farinati F; Ciccarese F; Rapaccini G; Marco MD; Benvegnù L; Zoli M; Borzio F; Caturelli E; Chiaramonte M; Trevisani F;
Liver Int; 2013 Nov; 33(10):1594-600. PubMed ID: 23654354
[TBL] [Abstract][Full Text] [Related]
6. Splenic arterial ligation prevents liver injury after a major hepatectomy by a reduction of surplus portal hypertension in hepatocellular carcinoma patients with cirrhosis.
Sato Y; Kobayashi T; Nakatsuka H; Yamamoto S; Oya H; Watanabe T; Hatakeyama K
Hepatogastroenterology; 2001; 48(39):831-5. PubMed ID: 11462934
[TBL] [Abstract][Full Text] [Related]
7. [Combined operations for patients with hepatic cancer complicated by portal hypertension].
Liu XG; Li CL; Lin JH; Liu ZJ; Yang JC
Di Yi Jun Yi Da Xue Xue Bao; 2002 Dec; 22(12):1106-8. PubMed ID: 12480586
[TBL] [Abstract][Full Text] [Related]
8. Benefits of Splenectomy and Curative Treatments for Patients with Hepatocellular Carcinoma and Portal Hypertension: a Retrospective Study.
Pei Y; Chai S; Zhang Y; Zhang Z; Chen X; Zhang W
J Gastrointest Surg; 2019 Nov; 23(11):2151-2162. PubMed ID: 30511133
[TBL] [Abstract][Full Text] [Related]
9. Neither multiple tumors nor portal hypertension are surgical contraindications for hepatocellular carcinoma.
Ishizawa T; Hasegawa K; Aoki T; Takahashi M; Inoue Y; Sano K; Imamura H; Sugawara Y; Kokudo N; Makuuchi M
Gastroenterology; 2008 Jun; 134(7):1908-16. PubMed ID: 18549877
[TBL] [Abstract][Full Text] [Related]
10. Open Radiofrequency Ablation Combined with Splenectomy and Pericardial Devascularization vs. Liver Transplantation for Hepatocellular Carcinoma Patients with Portal Hypertension and Hypersplenism: A Case-Matched Comparative Study.
Wang X; Sun X; Lei Y; Pei J; Ma K; Feng K; Lau WY; Xia F
J Invest Surg; 2023 Dec; 36(1):1-7. PubMed ID: 36345736
[TBL] [Abstract][Full Text] [Related]
11. [Surgical handling of primary hepatic carcinoma with severe cirrhosis and portal hypertension].
Li T; Pi Z; Liu G
Hunan Yi Ke Da Xue Xue Bao; 1997; 22(6):500-2. PubMed ID: 10072989
[TBL] [Abstract][Full Text] [Related]
12. The role of splenectomy in patients with hepatocellular carcinoma and secondary hypersplenism.
Oh JW; Ahn SM; Kim KS; Choi JS; Lee WJ; Kim BR
Yonsei Med J; 2003 Dec; 44(6):1053-8. PubMed ID: 14703616
[TBL] [Abstract][Full Text] [Related]
13. Appraisal of concomitant splenectomy in liver resection for hepatocellular carcinoma in cirrhotic patients with hypersplenic thrombocytopenia.
Wu CC; Cheng SB; Ho WM; Chen JT; Yeh DC; Liu TJ; P'eng FK
Surgery; 2004 Sep; 136(3):660-8. PubMed ID: 15349116
[TBL] [Abstract][Full Text] [Related]
14. Severity of portal hypertension and prediction of postoperative liver failure after liver resection in patients with Child-Pugh grade A cirrhosis.
Chen X; Zhai J; Cai X; Zhang Y; Wei L; Shi L; Wu D; Shen F; Lau WY; Wu M
Br J Surg; 2012 Dec; 99(12):1701-10. PubMed ID: 23132418
[TBL] [Abstract][Full Text] [Related]
15. Outcomes of liver resection for hepatocellular carcinoma in liver transplantation era.
Lee WC; Lee CF; Cheng CH; Wu TJ; Chou HS; Wu TH; Soong RS; Chan KM; Yu MC; Chen MF
Eur J Surg Oncol; 2015 Sep; 41(9):1144-52. PubMed ID: 26163047
[TBL] [Abstract][Full Text] [Related]
16. Role of splenectomy in patients with hepatocellular carcinoma and hypersplenism.
Kim SH; Kim DY; Lim JH; Kim SU; Choi GH; Ahn SH; Choi JS; Kim KS
ANZ J Surg; 2013 Nov; 83(11):865-70. PubMed ID: 22985446
[TBL] [Abstract][Full Text] [Related]
17. A Novel Technique for Synchronous Laparoscopic Splenectomy and Azygoportal Disconnection With Hepatectomy.
Jiang G; Bai D; Chen P; Qian J; Jin S
Surg Innov; 2018 Jun; 25(3):218-223. PubMed ID: 29529940
[TBL] [Abstract][Full Text] [Related]
18. [Long-term effect of united hepatectomy and splenectomy on treatment of hepatocellular carcinoma complicated with cirrhosis and hypersplenism].
Cai JQ; Hu JQ; Bi XY; Zhao JJ; Che X; Xie SL; Shao YF; Zhao P
Zhonghua Yi Xue Za Zhi; 2004 Jan; 84(1):6-8. PubMed ID: 14990147
[TBL] [Abstract][Full Text] [Related]
19. Measurement of portal venous pressure is useful for selecting the optimal type of resection in cirrhotic patients with hepatocellular carcinoma.
Kanematsu T; Furui J; Yanaga K; Okudaira S; Kamohara Y; Eguchi S
Hepatogastroenterology; 2005; 52(66):1828-31. PubMed ID: 16334786
[TBL] [Abstract][Full Text] [Related]
20. [An analysis of prognostic examination in cirrhotic portal hypertension and hepatoma].
Takeshige K; Yamamoto S; Kojima H; Arakawa T; Kuroda H; Kawai Y; Fukaya Y
Nihon Geka Gakkai Zasshi; 1986 Feb; 87(2):206-10. PubMed ID: 3012312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
